De Hulan

De Hulan is the Vice President and General Manager of Eli Lilly China. He highlighted the importance of the recent changes in the drug approval landscape in China, stating that the country has become a key strategic market for multinational pharmaceutical companies, with innovative drugs being rapidly approved and integrated into medical insurance systems.